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Abstract SHARPIN regulates immune signaling and contributes to full transcriptional activity and 
prevention of cell death in response to TNF in vitro. The inactivating mouse Sharpin cpdm mutation 
causes TNF-dependent multi-organ inflammation, characterized by dermatitis, liver inflammation, 
splenomegaly, and loss of Peyer's patches. TNF-dependent cell death has been proposed to cause 
the inflammatory phenotype and consistent with this we show Tnfr1, but not Tnfr2, deficiency 
suppresses the phenotype (and it does so more efficiently than Il1r1 loss). TNFR1-induced 
apoptosis can proceed through caspase-8 and BID, but reduction in or loss of these players 
generally did not suppress inflammation, although Casp8 heterozygosity significantly delayed 
dermatitis. Ripk3 or Mlkl deficiency partially ameliorated the multi-organ phenotype, and combined 
Ripk3 deletion and Casp8 heterozygosity almost completely suppressed it, even restoring Peyer's 
patches. Unexpectedly, Sharpin, Ripk3 and Casp8 triple deficiency caused perinatal lethality.  
These results provide unexpected insights into the developmental importance of SHARPIN.
DOI: 10.7554/eLife.03464.001
Introduction
Chronic proliferative dermatitis mutation (cpdm) mice are deficient in SHARPIN (Sharpincpdm/cpdm: 
henceforth referred to as Shpnm/m; protein: SHARPIN) and develop dermatitis, multi-organ pathology 
and an immunological phenotype including disrupted lymphoid architecture, splenomegaly, liver inflam-
mation and a loss of Peyer's patches in the gut (HogenEsch et al., 1993, 1999; Seymour et al., 
2007). SHARPIN is required for normal tumour necrosis factor (TNF) receptor 1 (TNFR1)-mediated gene 
induction and prevention of TNF-mediated death of various cells, including epidermal keratinocytes, 
in vitro (Gerlach et al., 2011; Ikeda et al., 2011; Tokunaga et al., 2011). The dermatitis is characterized 
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by epidermal cell death marked by cleaved caspase-3-, -8- and -9-positive cells (Ikeda et al., 2011; 
Liang and Sundberg, 2011; Potter et al., 2014). Since the dermatitis and inflammatory phenotype 
were shown to be TNF dependent, and because the only TNF signaling output that was aberrantly 
increased in the absence of SHARPIN was cell death, we previously proposed TNF/TNFR1-mediated 
cell death to be causative of the cpdm phenotype (Gerlach et al., 2011). The role of neither TNFR1 
nor cell death has been confirmed in vivo, however.
TNFR1 signaling typically involves the intracellular recruitment of TNFR1-associated death domain 
protein (TRADD), TNF receptor-associated factor 2 (TRAF2), cellular inhibitor of apoptosis (cIAPs), and 
receptor interacting protein kinase 1 (RIPK1) (Silke, 2011). The heterotrimeric linear ubiquitin chain 
assembly complex (LUBAC) of SHARPIN (also known as SIPL), HOIL-1 (RBCK1/RNF54) and HOIL-1L-
interacting protein (HOIP; RNF31) (Gerlach et al., 2011; Ikeda et al., 2011; Tokunaga et al., 2011) is 
also recruited to the TNFR1 signaling complex. Here, it assembles a linear ubiquitin scaffold needed 
for full recruitment of the NF-κB essential modulator (NEMO)/NF-κB kinase subunit gamma (IKKγ)-
containing IKK complex, which activates pro-survival NF-κB signaling. TNFR1-induced c-Jun N-terminal 
protein kinase (JNK) and p38 signaling is also regulated by LUBAC. SHARPIN deficiency blunts the 
TNFR1 pro-survival transcriptional signal and sensitizes cells to TNF-induced cell death. The E3 ligase 
activity of HOIP catalyzes the addition of linear ubiquitin to target proteins, and SHARPIN and HOIL-1 
are key regulators of the stability and activity of HOIP (Gerlach et al., 2011). In addition to TNFR1, 
LUBAC has also been shown to regulate the transcriptional response from the interleukin-1 receptor 
(IL-1R), CD40, lymphotoxin beta receptor (LTβR), toll-like-receptor 4 (TLR4), and nucleotide-binding 
oligomerization domain-containing protein 2 (NOD2) receptor signaling complexes (Schmukle and 
Walczak, 2012). Deletion of Il1rap, needed for IL-1 signaling, has been reported to almost completely 
prevent the development of cpdm dermatitis (Liang et al., 2010). This suggests that IL-1R signaling 
is a significant driver of disease, but the effect of Il1rap deficiency on the rest of the Shpnm/m pheno-
type was not reported.
Cpdm mice have prominent eosinophil infiltration into the skin; however, deletion of Il5, which dra-
matically reduces the number of cutaneous and circulating eosinophils, fails to ameliorate disease 
(Renninger et al., 2010). Shpnm/mRag1−/− mice lacking functional lymphocytes develop dermatitis, indi-
cating that T and B cell cells are not required for the skin phenotype (Potter et al., 2014). Furthermore, 
hematopoietic cell transfer with bone marrow and spleen cells from cpdm mice to syngeneic wild-type 
C57BL/Ka mice failed to transfer disease in mice 2 months post reconstitution. Finally, cpdm skin trans-
planted onto nude mice retained the donor dermatitis phenotype 3 months post transplant, while 
syngeneic healthy skin transplanted onto cpdm mice did not acquire the disease over the same time 
eLife digest In response to an injury or infection, areas of the body can become inflamed as the 
immune system attempts to repair the damage and/or destroy any microbes or toxins that have 
entered the body. At the level of individual cells inflammation can involve cells being programmed 
to die in one of two ways: apoptosis and necroptosis.
Apoptosis is a highly controlled process during which the contents of the cell are safely destroyed 
in order to prevent damage to surrounding cells. Necroptosis, on the other hand, is not controlled: 
the cell bursts and releases its contents into the surroundings.
Inflammation is activated by a protein called TNFR1, which is controlled by a complex that 
includes a protein called SHARPIN. Mice that lack the SHARPIN protein develop inflammation on 
the skin and internal organs, even in the absence of injury or infection. However, it is not clear how 
SHARPIN controls TNFR1 to prevent inflammation. Rickard et al. and, independently Kumari et al. 
have now studied this process in detail.
Rickard et al. cross bred mice that lack SHARPIN with mice lacking other proteins involved in 
inflammation and cell death. The experiments show that apoptosis is the main form of cell death  
in skin inflammation, but necroptosis has a bigger role in the inflammation of internal organs.
Mice that lack both the apoptotic and necroptotic cell-death pathways can develop relatively 
normally, but they die shortly after birth if they also lack SHARPIN. Experiments on these mice 
could help us to understand how SHARPIN works.
DOI: 10.7554/eLife.03464.002
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(HogenEsch et al., 1993; Gijbels et al., 1995). Together these studies indicate that a skin-intrinsic 
defect in cpdm mice drives the inflammatory disease, however they do not rule out a role for the 
hematopoietic system in amplifying it.
Impaired pro-survival TNFR1 signaling can induce both caspase-8-dependent apoptotic and 
RIPK3- and mixed lineage kinase domain-like protein (MLKL)-dependent necroptotic cell death via a 
cytosolic death platform (Micheau and Tschopp, 2003; He et al., 2009; Sun et al., 2012; Zhao et al., 
2012; Murphy et al., 2013). Necroptosis involves the release of cellular contents including potential 
damage-associated molecular patterns (DAMPs) such as mitochondrial DNA, high mobility group box 
1 protein (HMGB1), IL-33, and IL-1α (Kaczmarek et al., 2013). By contrast, apoptosis is considered 
to be immunologically silent, although this is clearly context dependent because excessive apoptosis 
resulting from conditional epidermal deletion of the caspase inhibitor cFLIP can cause severe skin 
inflammation (Panayotova-Dimitrova et al., 2013). Caspase-8 can cleave both RIPK1 and RIPK3 and 
is needed to keep the necroptotic pathway in check (Vandenabeele et al., 2010; Kaiser et al., 2011; 
Oberst et al., 2011). Regulation of necroptotic signaling is crucial for skin homeostasis because deletion 
of either caspase-8, the caspase-8 adaptor protein FADD (Fas-associated protein with death domain), 
or RIPK1, leads to RIPK3- and MLKL-dependent epidermal hyperplasia and inflammation (Kovalenko 
et al., 2009; Lee et al., 2009; Bonnet et al., 2011; Kaiser et al., 2011; Oberst et al., 2011; Dannappel 
et al., 2014; Dillon et al., 2014; Rickard et al., 2014).
Although the precise factors that determine whether TNFR1 mediates apoptosis or necroptosis 
are unclear, high levels of RIPK3, loss of cIAPs, and CYLD-mediated deubiquitylation of RIPK1 appear 
conducive to necroptosis (Silke and Vaux, 2014). In addition to a crucial role in necroptosis, RIPK3 
may also regulate inflammasome-induced IL-1ß production in the absence of IAPs or caspase-8 (Vince 
et al., 2012; Kang et al., 2013). Thus the effects of loss of RIPK3 on an inflammatory phenotype may 
not be due to loss of necroptotic cell death but to a less well-defined role in IL-1ß production. This 
complicates interpretation of the role of RIPK3 in a disease, particularly when IL-1 is pathogenic such 
as in cpdm dermatitis. MLKL is downstream of RIPK3 in necroptosis and appears not to be required for 
cytokine production in the same situations as RIPK3 (Wong et al., 2014). Thus Mlkl−/− mice may provide 
an opportunity to disentangle the relative contribution of necroptosis and deregulated cytokine pro-
duction in disease.
Here we provide genetic evidence in support of our hypothesis that TNFR1-induced cell death is a 
driver of the inflammatory disease in cpdm mice (Gerlach et al., 2011). We show that the cpdm 
phenotype is TNFR1 and cell-death dependent. Ripk3 or Mlkl deficiency largely prevented cpdm 
liver inflammation and ameliorated the splenic phenotype and leukocytosis. Remarkably, given the 
skin-inflammation phenotype of skin-specific Casp8 knock-out mice (Kovalenko et al., 2009; Lee 
et al., 2009), Casp8 heterozygosity potently suppressed the inflammatory skin phenotype while 
leaving the systemic inflammation unaffected. Strikingly, combined Ripk3 deficiency and Casp8 heter-
ozygosity completely prevented the cpdm dermatitis in all but one of the mice analyzed at 42 to 
45 weeks of age, prevented liver inflammation and grossly restored splenic architecture. Surprisingly, 
given the importance of LTßR (also known as TNFRSF3) signaling in the formation of Peyer's patches 
(De Togni et al., 1994; Koni et al., 1997) and the role of SHARPIN in this pathway (Tokunaga et al., 
2011), apparently normal Peyer's patches were also present in Shpnm/mCasp8+/-Ripk3−/− mice.
Results
Shpnm/m dermatitis is mediated by TNFR1, IL-1R to a lesser extent and 
not TNFR2
The dermatitis in Shpnm/m mice has previously been shown to be driven by TNF (Gerlach et al., 2011) 
and IL-1 signaling (Liang et al., 2010). Because the environment may influence the onset of the 
disease we wished to test the importance of TNF and IL-1 signaling in a head-to-head manner. 
Furthermore the relative contribution of TNFR1 and TNFR2 in cpdm dermatitis has not been deter-
mined. We therefore generated Shpnm/m mice deficient in Tnfr1, Tnfr2 or Il1r1 (Figure 1A). All the 
knock-out mouse strains used in this study have been backcrossed at least ten times onto C57BL/6, 
or were generated on the C57BL/6 background (Mlkl−/− mice). However, the cpdm mutation arose 
on a C57BL/Ka background (HogenEsch et al., 1993). To control for background modifier effects, 
we backcrossed C57BL/Ka Shpnm/m mice once or twice onto the C57BL/6 background, equivalent 
to the strategy we used in generating all our Shpnm/m compound knock-out strains to generate 
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Shpnm/m C57BL/6 control mice. These control mice developed the cpdm phenotype indistinguishably 
from the C57BL/Ka Shpnm/m mice, typically presenting with a visible skin phenotype by 5 to 6 weeks 
and invariably requiring euthanasia due to the dermatitis before 14 weeks of age. Tnfr2 deletion did 
not ameliorate the dermatitis but Shpnm/mTnfr1−/− mice showed no outward signs of disease even after 
35 weeks (Figure 1A–C). Il1r1 deletion significantly delayed the appearance of dermatitis, with mark-
edly reduced epidermal hyperplasia in 13-week-old Shpnm/mIl1r1−/− mice compared with 12-week-old 
Shpnm/m mice (Figure 1B,C). However, by 19–20 weeks, Shpnm/mIl1r1−/− mice typically developed disease 
and required euthanasia. Tnfr1 deletion reduced periportal liver inflammation and partially amelio-
rated the splenic phenotype, but did not restore Peyer's patches, whilst Tnfr2 and Il1r1 deletion did 
not prevent pathology in any of these organs (Figure 1B,D).
Keratinocyte cell death and dermal macrophage infiltration are early 
events in Shpnm/m dermatitis
To gain insight into the pathogenesis of cpdm dermatitis we assessed cytokine levels in skin lysates 
from 6-week-old cpdm and control mice using a BioPlex kit (BioRad) (Figure 2A) to determine which 
cytokines were elevated early in the disease process. TNF levels were slightly elevated (log scale, 
Figure 2A) and, consistent with reports of eosinophilia in cpdm mice (HogenEsch et al., 1993; Gijbels 
et al., 1996), IL-5 (a key inducer of eosinophil maturation) was also elevated. The monocyte and mac-
rophage chemoattractant protein MCP-1 was significantly elevated in cpdm skin, as was the IL-12 p40 
subunit. There was also a trend for macrophage inflammatory protein 1α (MIP-1α) levels to be elevated. 
Consistent with this, there was an increase in F4/80+ cells in the Shpnm/m dermis, and this was evident 
in patches at 3 weeks, before significant epidermal hyperplasia was present (Figure 2B). Ikeda et al. 
reported cleaved caspase-3-positive keratinocytes in 10-week-old Shpnm/m mice (Ikeda et al., 2011), 
and we found cleaved caspase-3-positive cells were already present in the epidermis of 3-week-old 
Shpnm/m mice, indicating that apoptosis is an early event in the dermatitis and occurs before significant 
hyperplasia (Figure 2C). There were slightly more cleaved caspase-3-positive cells in Shpnm/m livers 
than controls (almost exclusively in the infiltrating cells), however they were infrequent. An increased 
number of cleaved caspase-3-positive cells were detected in Shpnm/m spleens, but, again, were much 
less appreciable than in the epidermis (Figure 2C).
Reconstitution of wild-type mice with Shpnm/m bone marrow and/or spleen cells fails to transfer 
the disease (HogenEsch et al., 1993), suggesting a skin-intrinsic defect underlies cpdm dermatitis. 
These mice, however, were only followed for 8 weeks post reconstitution and this may not have 
allowed sufficient time for the dermatitis to develop. To test this possibility, we reconstituted wild-type 
mice with Shpnm/m bone marrow cells and followed them for 12 months. Reconstitution efficiency was 
high but the mice did not demonstrate any skin, liver, or spleen phenotype during this time (Figure 3). 
Collectively these results suggest that the hematopoietic system in isolation cannot cause Shpnm/m 
dermatitis, and that macrophages may play a role in the amplification of the disease, particularly given 
they can be a prominent source of TNF.
TNF induces cell death with caspase-3 and -8 cleavage in primary 
keratinocytes, mouse dermal fibroblasts and myeloid cells in vitro
Tnf deletion prevents cpdm dermatitis and TNF kills Shpnm/m keratinocytes in vitro, suggesting 
that TNF-induced cell death drives the Shpnm/m skin phenotype (Gerlach et al., 2011). Consistent 
with this, TNF-induced cell death in Shpnm/m keratinocytes that was partially blocked by Q-VD-OPh 
or Nec-1 treatment (Figure 4A). Shpnm/m mouse dermal fibroblasts (MDFs) were also sensitive to 
TNF-induced cell death, and this death was almost completely blocked by the RIPK1 kinase inhib-
itor Necrostatin-1 (Nec-1), but not by the pan-caspase inhibitor Q-VD-OPh (Figure 4B). To test 
whether TNF could induce caspase cleavage we treated primary Shpnm/m keratinocytes and MDFs with 
TNF for up to 4 hr (Figure 4C,D, Figure 4—figure supplement 1). TNF treatment led to caspase-3 
and -8 cleavage at 4 hr in Shpnm/m, but not wild-type, keratinocytes. In Shpnm/m MDFs there was also 
caspase-3 and -8 cleavage, and, surprisingly, this was reduced by Nec-1, but not Q-VD, treatment 
(Figure 4D). In Shpnm/m keratinocytes and MDFs, the increased caspase-8 activity coincided with 
a marked processing of cFLIP, but other outcomes of the signaling pathway were less obviously 
affected. Together with the early presence of cleaved caspase-3 staining and the elevation of TNF 
in Shpnm/m skin, these results indicate that TNF-induced apoptosis may play a pathogenic role in the 
skin phenotype.
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Figure 1. Cpdm dermatitis is mediated by TNFR1, IL-1R to a lesser extent, and not TNFR2. (A) Representative 
photos of mice of indicated genotypes and age. (B) Histological analysis of mice of genotype and age as indicated; 
representative of n ≥ 3 mice for each genotype or group. Black arrows in liver images point to areas of periportal 
inflammation. Black arrows in small intestine image point to Peyer's patches. Shpnm/m: Sharpincpdm/cpdm. Control 
mice are Shpn+/+ or +/m, Tnfr1−/− control mice are Shpn+/+ or +/mTnfr1−/−. Scale bars: Skin and liver 100 µm, spleen 500 µm, 
Figure 1. Continued on next page
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Given the appearance of cleaved caspase-3-positive cells in the Shpnm/m dermis (Figure 2C), we 
sought to determine whether some of these might be non-fibroblast cells such as immune cells. Since 
lymphoid cells are not required for cpdm dermatitis (Potter et al., 2014) and macrophage infiltration 
appears early, we tested whether myeloid cells were also sensitive to TNF-induced death. Shpnm/m 
neutrophils, monocytes and bone-marrow-derived macrophages (BMDMs) were all sensitive to killing 
by TNF, whereas the wild-type cells were not (Figure 4E). Neutrophil and monocyte cell death was 
more efficiently blocked by a combination of Nec-1 and Q-VD, whereas in macrophages Nec-1 was 
sufficient to block cell death. These data suggest that myeloid cell death may contribute to the inflam-
matory skin phenotype.
The catalytic LUBAC component HOIP, like SHARPIN, is required to 
protect keratinocytes against TNF-induced death
We did not detect a defect in p38, JNK or NF-κB pro-survival signaling in SHARPIN-deficient keratino-
cytes and MDFs, as has been shown for other cell types (Gerlach et al., 2011; Ikeda et al., 2011; 
Tokunaga et al., 2011). Consistent with earlier reports (Gerlach et al., 2011; Peltzer et al., 2014), 
however, using an antibody that specifically recognises linear ubiquitin we detected substantially 
reduced linear ubiquitylation in the native TNFR1 signaling complex obtained from Shpnm/m vs wild-
type mouse embryonic fibroblasts (MEFs) (Figure 5A). We also found that HaCaT keratinocytes 
(a human immortalized cell line) stably expressing catalytically inactive HOIPC885S were sensitive to 
TNF-induced cell death (Figure 5B), indicating a requirement for LUBAC and its linear-ubiquitin-
chain-forming activity in preventing TNF-induced keratinocyte death.
Casp8 heterozygosity, but not Bid deficiency, delays onset of cpdm 
dermatitis
To investigate the importance of the caspase-8-mediated apoptotic pathway in vivo we generated 
Shpnm/mCasp8+/− mice. We did not attempt to generate Shpnm/mCasp8−/− mice because Casp8 dele-
tion results in embryonic lethality at around E10.5 (Varfolomeev et al., 1998). In contrast to Shpnm/m 
mice, 12-week-old Shpnm/mCasp8+/− mice had almost no epidermal hyperplasia and largely normal 
keratin 6 and 14 expression (Figure 6A,B). By 15 weeks of age, however, significant hyperplasia 
was observed in one of these mice (Figure 6B). Shpnm/mCasp8+/− mice retained other aspects of the 
phenotype: splenomegaly with disrupted splenic architecture, liver inflammation, and a lack of intes-
tinal Peyer's patches (Figure 6C). Some Shpnm/mCasp8+/− mice succumbed to a pulmonary infec-
tion with Pasteurella and required euthanasia while littermates were unaffected, suggesting that 
Shpnm/mCasp8+/− mice are partially immunocompromised. Mice with obvious signs of infection were 
not used for the spleen, blood, or liver analyses but were included in the skin analysis. Occult infec-
tion, however, in Shpnm/mCasp8+/− mice used for hematopoietic, liver, and spleen analyses cannot be 
completely excluded.
In certain cell types such as hepatocytes, BID can be cleaved by caspase-8 to generate truncated 
BID (tBID) that, in turn, mediates caspase-9- and mitochondria-dependent apoptosis (Czabotar et al., 
2014). BID is a key regulator of UV-induced apoptosis in keratinocytes, indicating that this pathway 
is of importance in the skin (Pradhan et al., 2008). Because cleaved caspase-9 is found in the 
Shpnm/m epidermis (Ikeda et al., 2011) and Shpnm/m keratinocyte extracts contained caspase-9-substrate-
cleaving activity (Liang and Sundberg, 2011), we hypothesized that TNF-induced BID-dependent 
apoptosis may be a driver of the cpdm phenotype and, hence, generated Shpnm/mBid−/− mice. We 
small intestine 1 mm. H&E: hematoxylin and eosin. (C) Epidermal thickness of mice of indicated age and genotypes. 
Each point represents the average of at least 14 measurements from multiple fields of view per mouse that were 
taken by a researcher who was blind to the genotype. Dotted lines are drawn at 30 µm and 14 weeks. Red numbers 
(and black for middle graph) correspond to proportion of Shpnm/m mice with epidermal thickness >30 µm at < 14 weeks 
of age (upper left quadrant). Control mice are Shpn+/+ or +/m, Shpn+/+ or +/mTnfr1−/− and Shpn+/+ or +/mIl1r1−/− in upper, 
middle and lower graphs respectively. *** Significantly different to control group (Fisher's exact test), p ≤ 0.005.  
(D) Average spleen weights of mice of indicated genotypes. Spleen weights were taken from 12-week-old mice 
(except Tnfr1−/− mice that were 15 or 35 weeks old), or younger mice if they required euthanasia due to their 
dermatitis. Data are represented as mean + SEM, *p ≤ 0.05, ***p ≤ 0.005.
DOI: 10.7554/eLife.03464.003
Figure 1. Continued
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observed no protection from any aspects of the cpdm phenotype (Figure 6A–D), however, indicat-
ing that caspase-8, but not BID, is an important driver of this disease.
Ripk3 deletion slightly delays Shpnm/m dermatitis, and Ripk3 and Mlkl 
deletion partially protects against the cpdm splenic phenotype and 
markedly attenuates liver inflammation
Caspase-8 heterozygosity significantly delayed epidermal hyperplasia, but other aspects of the 
cpdm phenotype (e.g. splenomegaly and liver inflammation) remained. We therefore sought to test 
the role of necroptosis in the inflammatory disease by generating Shpnm/mRipk3−/− mice. Whereas con-
trol mice invariably developed severe dermatitis by 12 weeks of age, roughly half of the 12-week-old 
Shpnm/mRipk3−/− mice had a less severe epidermal phenotype at this point (Figure 7A,B). When aged 
over 12 weeks, all Shpnm/mRipk3−/− animals went on to develop severe disease and were eutha-
nized due to their skin phenotype before 18 weeks of age. The remainder of Shpnm/mRipk3−/− mice 
developed skin disease at the same rate as control mice. 12 week-old Shpnm/mRipk3−/− mice had no 
signs of liver inflammation and significantly less splenomegaly, although they still lacked Peyer's 
Figure 2. Keratinocyte cell death and dermal macrophage infiltration are early events in cpdm dermatitis.  
(A) BioPlex cytokine analysis of skin lysates from mice of indicated genotypes. Data are represented as mean 
+S.E.M. *p ≤ 0.05. (B) F4/80 staining (brown) of skin sections counterstained with hematoxylin (blue). Control: 
Shpn+/+ or +/m. (C) Cleaved caspase-3 staining (brown) of skin, liver and spleen sections counterstained with  
hematoxylin (blue). Black arrows show examples of cleaved-caspase-3 positive cells. Control: Shpn+/+ or +/m.  
(A–C) Three mice were analyzed for each genotype or group. Scale bars: 50 µm.
DOI: 10.7554/eLife.03464.004
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Figure 3. No dermatitis in wild-type mice reconstituted with Shpnm/m bone marrow after 12 months. (A) No dermatitis was observed in wild-type mice  
12 months after reconstitution with Shpnm/m bone marrow. (B) Flow cytometry analysis showing percentage contribution of Ly5.1 (recipient) vs Ly5.2 
(donor) white blood cells in peripheral blood 12 months after reconstitution. (C) Histological and immunofluorescence analysis of dorsal skin from mice 
12 months after reconstitution. (D) Histological analysis of the spleen and liver from mice 12 months after reconstitution. Scale bars: Skin 100 µm, liver 
200 µm and spleen 500 µm. H&E: hematoxylin and eosin.
DOI: 10.7554/eLife.03464.005
patches (Figure 7C,D). We also generated Shpnm/mMlkl−/− mice and found they had a similar epi-
dermal phenotype to Shpnm/m mice (Figure 7B). Like Shpnm/mRipk3−/− mice, however, 12-week-old 
Shpnm/mMlkl−/− animals had reduced splenomegaly and only one out of 12 mice showed signs of 
liver inflammation (Figure 7C,D). Collectively these results indicate that RIPK3 and MLKL are impor-
tant drivers of the liver and splenic cpdm phenotype, and that RIPK3 contributes to the epidermal 
phenotype, importantly in a non-MLKL-dependent (hence, most likely, necroptosis-independent) 
manner.
Shpnm/mCasp8-/-Ripk3−/− mice are prone to perinatal lethality
Since deletion neither of one allele of Casp8 nor of two alleles of Ripk3 was able to fully rescue all 
the multi-organ pathology in cpdm mice, we sought to generate Shpnm/mCasp8−/−Ripk3−/− mice, taking 
advantage of the fact that Ripk3 deletion prevents Casp8−/−-mediated embryonic lethality (Kaiser 
et al., 2011; Oberst et al., 2011). We generated these mice independently at two separate facilities. 
At one facility, most of these triple-deficient mice died perinatally, typically in a window between 
E17 and 1 to 2 days after birth, and no Shpnm/mCasp8-/-Ripk3−/− animals were obtained at weaning 
(Figure 8A,B; numbers in A refer to mice analyzed at first facility only). Most Shpnm/mCasp8−/−Ripk3−/− 
embryos obtained by Caesarean section at E19 appeared edematous or were dead. Some were able to 
breathe; however, these died within the first 2 days after birth. Hematopoietic analysis at E19 did not 
reveal any consistent differences (Figure 8C). At a separate facility, two viable Shpnm/mCasp8−/−Ripk3−/− 
mice were obtained from a limited number of matings. By roughly 3 months of age these mice 
appeared runted and were euthanized. Histologically these mice had no epidermal phenotype, but 
disrupted splenic architecture was apparent (Figure 8D).
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Figure 4. TNF induces death in multiple primary cell types, and is marked by caspase-3 and -8 cleavage in primary keratinocytes and mouse dermal 
fibroblasts in vitro. (A and B) Primary keratinocytes (A) and mouse dermal fibroblasts (MDFs) (B) were treated with 100 ng/ml human Fc-TNF, 50 µM Nec-1 
or 10 µM Q-VD-OPh for 24 hr as indicated, then viability was assessed by propidium iodide (PI) uptake and flow cytometry. Cells were generated from 
Figure 4. Continued on next page
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Casp8 heterozygosity and Ripk3 deletion markedly delays Shpnm/m 
phenotype
While the reason for the lethality of the triple-deficient animals is unknown, we were readily able to 
obtain viable Shpnm/mCasp8+/−Ripk3−/− mice. These mice were indistinguishable from control mice at 
12 weeks of age and had no skin, liver, or spleen pathology (Figure 9A–E). Remarkably, Peyer's 
patches were present (Figure 9C, Figure 9—figure supplement 1). One 67-week-old and three 
45-week-old Shpnm/mCasp8+/−Ripk3−/− mice had no signs of any skin phenotype, however another 
mouse developed dermatitis at 42 weeks (Figure 9A,B,D; note that epidermal thickness was not 
quantified for the 42-week-old mouse).
Shpnm/m leukocytosis is largely mediated by Ripk3 and Mlkl
To investigate the effect of the various genetic crosses on Shpnm/m leukocytosis, we analyzed white 
blood cell levels in peripheral blood using an ADVIA hematological analyzer (Figure 10). Tnfr1 dele-
tion was more effective at reducing leukocyte numbers than Tnfr2 or Il1r1 deletion, although all of 
these compound knock-out mice had leukocyte subsets that were elevated compared to controls. 
Caspase-8 heterozygosity or Bid deletion did not prevent the leukocytosis, whereas Ripk3 and Mlkl 
deletion markedly reduced it, suggesting the hematopoietic phenotype is driven predominantly 
by necroptosis. Shpnm/mRipk3−/− and Shpnm/mMlkl−/− mice still had elevated neutrophils, however 
Shpnm/mCasp8+/−Ripk3−/− mice had no white blood cell elevation.
Discussion
LUBAC, composed of three proteins, HOIL-1, HOIP and SHARPIN, has recently emerged as a regulator 
of a diverse set of signaling complexes (Zak et al., 2011; Schmukle and Walczak, 2012; Tokunaga, 
2013). Lack of HOIP causes mid-gestational embryonic lethality (embryonic day 10.5), and this is pre-
vented by simultaneous loss of Tnfr1 (Peltzer et al., 2014). Together, these data demonstrate that 
LUBAC is required for full-strength IL-1ß and TNF signaling and deficiency in these signaling path-
ways would be expected to impair an inflammatory response. The consequence, however, of Sharpin 
deficiency in mice is multi-organ inflammation (HogenEsch et al., 1993). Likewise, loss-of-expression 
and loss-of-function mutations in HOIL-1 result in a fatal, human, inherited disorder characterized by 
chronic inflammation; consistent with loss of the major defensive inflammatory signaling pathways, 
affected patients suffer from invasive bacterial infections (Boisson et al., 2012). In vitro experiments 
suggest that HOIL-1 is an essential component of LUBAC, which is present in many cell types. With 
this in mind it is surprising that HOIL-1-deficient mice were reported to be normal (Tokunaga et al., 
2009). If, however, we set this observation to one side, it seems that in humans and mice loss of 
LUBAC can precipitate an inflammatory disease. This could be because the loss of the homeostatic 
component of TNFR1, IL-1R1, and TLR signaling reduces the ability of an organism to resist infection, 
which, even in the weakened signaling environment of LUBAC deficiency, drives inflammatory signal-
ing. Another possibility is that full-strength signaling from TNF, IL-1ß, or TLR ligands is required to 
upregulate essential negative feedback regulators such as IκBα and A20. Signaling, therefore, although 
reduced, is constitutively active. This explanation seems less likely because IκBα and A20 transcripts 
were still upregulated in response to TNF or Pam3CSK4 in HOIL-1/HOIP-deficient and cpdm cells 
(Haas et al., 2009; Tokunaga et al., 2009; Gerlach et al., 2011; Zak et al., 2011).
three different mice for each group. Control: Shpn+/+ or +/m. (C and D) Western blot analysis of primary keratinocytes (C) and MDFs (D) treated as indicated 
(concentrations as in A and B) then lysed and lysates separated on SDS/PAGE and western blotted with indicated antibodies. Shpn+/m: n = 1; Shpnm/m:  
n = 2 (n = 1 for MDFs) mice analyzed shown above. * Indicates non-specific band. Data from additional mice is shown in Figure 4—figure supplement 1. 
(E) Neutrophils, monocytes and bone-marrow-derived macrophages were treated with 100 ng/ml human Fc-TNF, 50 µM Nec-1, 20 µM Q-VD-OPh (10 µM 
for macrophages) or 500 nM Compound A (CpdA) for 20 hr (24 hr for macrophages) as indicated. Viability was assessed by PI uptake and flow cytometry. 
The Smac mimetic CpdA sensitizes cells to TNF-induced cell death and serves as a control. Cells were generated from three different mice for each 
group except for macrophages, where six to eight mice were analyzed. (A, B, E) Data are represented as mean + SEM, *p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.005.
DOI: 10.7554/eLife.03464.006
The following figure supplement is available for figure 4:
Figure supplement 1. TNF induces caspase-3 and -8 cleavage in primary keratinocytes and mouse dermal fibroblasts in vitro. 
DOI: 10.7554/eLife.03464.007
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The fact that the phenotype from the cpdm mice could not be transferred by the hematopoietic 
compartment, and that the skin phenotype is maintained following skin transplantation onto nude 
mice, indicates that these animals suffer from an intrinsic skin defect (HogenEsch et al., 1993; Gijbels 
et al., 1995). This is not unprecedented; loss of Notch signaling in the skin causes a dermatitis disease 
in mice that is sufficient to drive systemic inflammation with similar features to the cpdm phenotype 
(Dumortier et al., 2010). The earlier hematopoietic reconstitution experiments, however, may not 
have allowed sufficient time for the inflammatory phenotype to develop. The work described here 
excludes this caveat because reconstituted mice did not develop signs of the cpdm phenotype even a 
year after reconstitution; thus, the inflammatory skin phenotype in the Shpnm/m mutant mice is the 
result of an intrinsic skin defect. It is, however, noteworthy that loss of Mlkl did not affect the 
Shpnm/m skin phenotype but significantly reduced or prevented splenomegaly and liver inflammation. 
Conversely, reduction in caspase-8 markedly ameliorated the skin phenotype but did not prevent 
splenomegaly or liver inflammation. This shows that the skin and systemic phenotype are separable, 
although the exact mechanism is unclear.
The fact that cpdm keratinocytes are sensitized to TNF-induced apoptosis and necroptosis led us 
to hypothesize that TNF/TNFR1-dependent cell death was causative for the skin phenotype (Gerlach 
et al., 2011). Because of the systemic inflammation we suspected that necroptotic cell death and the 
release of DAMPs was the driver. Consistent with this hypothesis, we show here that Tnfr1 deficiency 
(as with Tnf deficiency) suppresses the cpdm phenotype, whereas Tnfr2 deficiency had no effect on the 
phenotype. Loss of IL-1 signaling has been shown to suppress the cpdm phenotype (Liang et al., 
2010), but because the environment of the mice likely plays a large part in the onset and severity of 
the inflammatory disease it was not possible to determine whether loss of IL-1 signaling is as potent as 
Tnf deficiency at preventing the phenotype. We therefore generated Shpnm/mIl1r1−/− mice, which suc-
cumbed to the inflammatory disease much later than Shpnm/m mice, but were far more inflammation 
prone than any of the Shpnm/mTnf−/+, Shpnm/mTnf−/−, or Shpnm/mTnfr1−/− mice. These data are again con-
sistent with our original hypothesis, suggesting that TNF/TNFR1 signaling is the main driver of inflam-
mation and that IL-1 contributes to exacerbating the disease.
Casp8 deficiency results in early embryonic lethality in mice (Varfolomeev et al., 1998), and loss of 
Casp8 or Fadd in the skin leads to keratinocyte hyperplasia and inflammatory skin disease (Kovalenko 
et al., 2009; Bonnet et al., 2011). Therefore, we considered it unlikely that loss of caspase-8 would 
Figure 5. Sharpin is required for normal linear ubiquitylation of the TNF-R1 signaling complex, and HOIP protects 
keratinocytes from TNF-induced cell death. (A) Anti Flag Immuno-Precipitation (IP) of the TNF receptor signaling 
complex in immortalised mouse embryonic fibroblasts (MEFs) treated with Flag-TNF for the times indicated.  
(B) HaCaT human keratinocytes stably expressing HOIP, the catalytically inactive HOIPC885S, or an empty vector 
(control) were treated with 100 ng/ml TNF for 24 hr. Viability was assessed by propidium iodide (PI) uptake and  
flow cytometry. Data are presented as mean + SEM, n = 3, *p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.005.
DOI: 10.7554/eLife.03464.008
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diminish the chronic proliferative dermatitis of the Shpnm/m mutant mice. To our surprise, however, 
loss of a single allele of Casp8 was strikingly effective at reducing the skin phenotype and appearance 
of cleaved caspase-3 in the skin. It has been proposed that the intrinsic mitochondrial apoptosis 
pathway mediated by caspase-9 and caspase-3 plays a role in the keratinocyte hyperplasia observed 
Figure 6. Protection from cpdm dermatitis with Casp8 heterozygosity but not Bid deletion. (A) Histological and immunofluorescence skin analysis.  
(B) Epidermal thickness of mice of indicated age and genotypes determined as in Figure 1B, by an investigator blinded to genotype. Top panel is a 
repeat of data in 1B for reference purposes only. Dotted lines are drawn at 30 µm and 14 weeks. Red numbers correspond to proportion of Shpnm/m mice 
with epidermal thickness >30 µm at < 14 weeks of age (upper left quadrant). Control mice are Shpn+/+ or +/m, Shpn+/+ or +/mBid−/−, and Shpn+/+ or +/mCasp8+/− 
in upper, middle and lower graphs, respectively. *** Significantly different to control group (Fisher's exact test), p ≤ 0.005. (C) Histological analysis of 
spleen, liver, and small intestine. Black arrows in liver images point to areas of periportal inflammation. Black arrow in small intestine image points to 
Peyer's patch. (D) Average spleen weights of mice of indicated genotypes. Spleen weights were taken from 12–14-week-old mice, or younger mice if 
they required euthanasia due to their dermatitis. Data are represented as mean + SEM, ***p ≤ 0.005. (A and C) Control mice are Shpn+/+ or +/m, n ≥ 3 mice 
analyzed each genotype or group. Scale bars: skin and liver 100 µm, spleen 500 µm, small intestine 1 mm. H&E: hematoxylin and eosin.
DOI: 10.7554/eLife.03464.009
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in Shpnm/m mutant mice based on the presence of disrupted mitochondria in cpdm skin and in vitro 
experiments (Liang and Sundberg, 2011). Given the prominent role that caspase-8 plays in the 
dermatitis, it would be expected that if the intrinsic apoptosis pathway is engaged it should be 
Figure 7. Ripk3 deficiency slightly delays cpdm dermatitis onset, and Ripk3 and Mlkl deficiency partially protects against the cpdm splenic phenotype 
and markedly attenuates liver inflammation. (A) Histological and immunofluorescence skin analysis. (B) Epidermal thickness of mice of indicated age and 
genotypes determined as in Figure 1B, by an investigator blinded to genotype. Top panel is a repeat of data in 1B for reference purposes only. Dotted 
lines are drawn at 30 µm and 14 weeks. Red numbers correspond to proportion of Shpnm/m mice with epidermal thickness >30 µm at < 14 weeks of age 
(upper left quadrant). Control mice are Shpn+/+ or +/m, Shpn+/+ or +/mRipk3−/−, and Shpn+/+ or +/mMlkl−/− in upper, middle and lower graphs, respectively.  
*** Significantly different to control group (Fisher's exact test), p ≤ 0.005, # significantly different to Shpnm/m mice (Fisher's exact test), p ≤ 0.05. (C) Histological 
analysis of spleen, liver, and small intestine. Black arrows in liver image points to areas of periportal inflammation. Black arrows in small intestine image 
points to Peyer's patches. (D) Average spleen weights of mice of indicated genotypes. Spleen weights were taken from 12-week-old mice, or younger mice 
if they required euthanasia due to their dermatitis. Data are represented as mean + SEM, ***p ≤ 0.005. (A and C) Control mice are Shpn+/+ or +/m, n ≥ 3 mice 
analyzed each genotype or group. Scale bars: skin and liver 100 µm, spleen 500 µm, small intestine 1 mm. H&E: hematoxylin and eosin.
DOI: 10.7554/eLife.03464.010
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Figure 8. Shpnm/mCasp8−/−Ripk3−/− mice are prone to perinatal lethality. (A) Table of segregation of expected and observed genotypes from  
Shpn+/mCasp8-/-Ripk3−/− or Shpnm/mCasp8+/-Ripk3−/− intercrosses at various developmental stages. E10.5 controls: Shpn+/+ or +/mCasp8-/-Ripk3−/−;  
E19 controls: Shpnm/mCasp8+/+ or +/−Ripk3−/−; weaning controls: Shpn+/+ or +/mCasp8−/−Ripk3−/− or Shpnm/mCasp8+/+ or +/−Ripk3−/−. *Significantly different to 
expected value, Fisher's exact test p < 0.0005. (B) Photos of E19 embryos obtained by Caesarian section. The Shpnm/mCasp8−/−Ripk3−/− mouse on the 
right was recovered dead, all others were alive. Other embryos are control mice: Shpnm/mCasp8+/+ or +/−Ripk3−/−. (C) ADVIA blood analysis from E19 embryos. 
RBC: red blood cells; WBC: white blood cells; MCV: mean cell volume. Horizontal lines depict data means. Control mice: Shpnm/mCasp8+/+ or +/−Ripk3−/−. 
(D) Histological analysis of tissue from 12-week-old mice of indicated genotypes. Mice were from a separate facility to those in A–C and are not included 
in the table in A. Two mice were analyzed for each genotype. Scale bars: skin 100 µm, spleen 50 µm.
DOI: 10.7554/eLife.03464.011
downstream of caspase-8 and require cleavage of the BH3 protein, BID (Czabotar et al., 2014). Cells 
that require BID cleavage by caspase-8 in order to undergo apoptosis are known as type II cells 
(Barnhart et al., 2003), but it is unclear whether keratinocytes are type I or type II (Pradhan et al., 
2008; Geserick et al., 2014). Genetic deletion of Bid did not suppress the dermatitis or any other 
aspect of the cpdm phenotype, therefore we conclude that the intrinsic mitochondrial pathway is 
unlikely to play a significant role in the disease.
Because necroptotic cell death can be inflammatory, by provoking the release of DAMPs, we 
expected that deficiency in RIPK3 or MLKL, essential effectors of the necroptotic cell death path-
way, would reduce the severity of the inflammation in Shpnm/m mice. Whilst there was a modest delay 
in the appearance of the dermatitis in Shpnm/mRipk3−/− mice, all animals went on to develop severe 
skin disease. In contrast to RIPK3 deficiency, deletion of Mlkl did not even delay appearance of the 
dermatitis. Together, this suggests that RIPK3 may exacerbate the skin phenotype independently 
of necroptosis, possibly via a direct role in cytokine production. Combined with the markedly ame-
liorated dermatitis seen in Shpnm/mCasp8+/− mice, this indicates that apoptosis is the main driver of 
Shpnm/m dermatitis. Although apoptosis is generally regarded as being immunologically inert, when in 
excess it can result in severe inflammation. For example, conditional deletion of cFLIP in adult keratino-
cytes caused severe inflammation in the epidermis (Panayotova-Dimitrova et al., 2013). Like the cpdm 
phenotype, this inflammation was TNF dependent. An excess of apoptotic cells may cause disease by 
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Figure 9. Ripk3 deletion and Casp8 heterozygosity markedly delays emergence of cpdm dermatitis and liver inflammation and restores Peyer’s patches. 
(A) Representative photos of mice of indicated genotypes and age. Three Shpnm/mCasp8+/-Ripk3−/− mice were analyzed at 45 weeks and one at 67 weeks 
with no detectable dermatitis, however another mouse developed dermatitis by 42 weeks of age. (B) Histological and immunofluorescence skin analysis. 
(C) Histological analysis of spleen, liver, and small intestine. Black arrows in liver image point to areas of periportal inflammation. Black arrows in small 
intestine images point to Peyer's patches. (D) Epidermal thickness of mice of indicated age and genotypes measured as described in Figure 1B. Top 
panel is a repeat of data in 1B for reference purposes only. Dotted lines are drawn at 30 µm and 14 weeks. Red numbers correspond to proportion of 
Shpnm/m mice with epidermal thickness >30 µm at < 14 weeks of age (upper left quadrant). Control mice are Shpn+/+ or +/m and Shpn+/+ or +/mCasp8+/−Ripk3−/− 
in upper and lower graphs, respectively. *** Significantly different to control group (Fisher's exact test), p ≤ 0.005. (E) Average spleen weights of mice of 
indicated genotypes. Spleen weights were taken from 12-week-old mice, or younger mice if they required euthanasia due to their dermatitis. Data are 
represented as mean + SEM, ***p ≤ 0.005. (B and C) Control mice are Shpn+/+ or +/m, n ≥ 3 mice analysed each genotype or group. Scale bars: skin and 
liver 100 µm, spleen 500 µm, small intestine 1 mm. H&E: hematoxylin and eosin.
DOI: 10.7554/eLife.03464.012
The following figure supplement is available for figure 9:
Figure supplement 1. Restoration of Peyer's patches in 8-week-old Shpnm/mCasp8+/−Ripk3−/− mice. 
DOI: 10.7554/eLife.03464.013
overwhelming phagocytosis and clearance of apoptotic bodies, leading to secondary necrosis and 
DAMP release. It has also been proposed that in certain contexts, such as viral infections, apoptosis 
may be inflammatory (Cullen et al., 2013). In other Shpnm/m organs such as the liver, spleen, and hema-
topoietic system, Ripk3 and Mlkl deletion ameliorated or protected against disease, indicating that 
Sharpin deficiency triggers apoptosis in some tissues but necroptosis in others. Because it has been 
shown that RIPK3 or MLKL can mediate cytokine production induced by the absence of caspase-8 
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Figure 10. Peripheral blood counts from various crosses. Peripheral blood was collected from 11–14-week-old mice 
(reconstituted mice: Shpnm/m → wild type were 12 months old and Tnfr1−/− mice were 35 weeks old), or younger  
Figure 10. Continued on next page
Cell biology | Developmental biology and stem cells
Rickard et al. eLife 2014;3:e03464. DOI: 10.7554/eLife.03464 17 of 23
Research article
(Kang et al., 2013), and potentially other, as yet undescribed, pathways, we cannot completely 
exclude the possibility that Ripk3 or Mlkl deletion affords protection by blunting cytokine production. 
Absence of SHARPIN, however, leads to increased, not decreased, caspase-8 activity, so it is not 
obvious whether these observations apply in this case. Furthermore, whereas it is clear that RIPK3 
plays a role in promoting cytokine production in response to a number of stimuli (Vince et al., 2012), 
we have so far only observed a defect in necroptosis and not in inflammatory cytokine production in 
Mlkl−/− cells (Murphy et al., 2013; Allam et al., 2014; Rickard et al., 2014).
Whilst Shpnm/mCasp8+/−, Shpnm/mRipk3−/−, and Shpnm/mMlkl−/− mice all developed significant disease 
in either the liver, spleen, hematopoietic compartment, or skin, Shpnm/mCasp8+/−Ripk3−/− mice were 
almost completely protected from disease for approximately 10–11 months, and in one case 15 months. 
One of these mice developed the skin phenotype at 10 months of age, indicating that the single 
allele of Casp8 is enough to eventually cause dermatitis. This is supported by the development of 
epidermal phenotype in 14–15-week-old Shpnm/mCasp8+/− mice. SHARPIN has been shown to regulate 
LTß/LTßR signaling, and LTßR is required for the development of Peyer's patches (De Togni et al., 
1994), therefore we had assumed that the absence of Peyer's patches was due to defective LTßR 
signaling. A recent study, however, demonstrated that rudimentary Peyer's patches formed in Shpnm/m 
embryos, but that these regressed post-natally (Seymour et al., 2013). Our data show that whilst 
neither Casp8 heterozygosity nor Ripk3 deletion in isolation restored intestinal Peyer's patches, the 
combination was able to do so. This suggests that the post-natal regression of these secondary lym-
phoid organs in Shpnm/m mice is due to deregulated cell death.
In a wider sense, our results are particularly important when interpreting the recent finding that 
crossing cpdm mice with Ripk1K45A/K45A mice (which lack RIPK1 kinase activity) completely suppresses 
the cpdm phenotype (Berger et al., 2014). RIPK1 has a promiscuous role in immune signaling, regu-
lating pro-survival, necroptotic, and apoptotic pathways. However, while the RIPK1 kinase domain is 
well known for its ability to activate the necroptotic pathway, it is not believed to be required to cause 
apoptosis (Vandenabeele et al., 2010). Yet we show here that the Shpnm/m skin phenotype is associ-
ated with the appearance of processed caspase-3 in the skin, and both the epidermal hyperplasia and 
appearance of processed caspase-3 is markedly reduced by loss of a single allele of Casp8. Consistent 
with the hypothesis that Shpnm/m keratinocyte hyperplasia is due to apoptosis, it is not prevented by loss 
of the key necroptotic effector MLKL. Furthermore, purified Shpnm/m keratinocytes and dermal fibro-
blasts rapidly activate caspase-8 and caspase-3 in response to TNF. Taken together with the work of 
Berger et al. our work inescapably suggests that in the context of the Shpnm/m epidermis the dominant 
role of the RIPK1 kinase domain is to activate apoptosis. Unexpectedly, but supporting this conclusion, 
we showed that Nec-1 (the RIPK1 kinase inhibitor) blocked TNF-induced caspase-8 and caspase-3 activa-
tion in Shpnm/m dermal fibroblasts. This conclusion is particularly confronting because we and others have 
shown that loss of RIPK1 in the skin results in a RIPK3/MLKL-dependent hyperplasia that is presumably 
dependent on necroptosis (Dannappel et al., 2014; Rickard et al., 2014). Thus RIPK1 is able to both 
activate and inhibit either apoptosis or necroptosis in a highly context-dependent manner.
Ripk3 deletion prevents the embryonic lethality seen with either Fadd or Casp8 deletion and the 
mice survive to adulthood (Kaiser et al., 2011; Oberst et al., 2011; Dillon et al., 2012). Given this, 
the perinatal lethality we observed in Shpnm/mCasp8−/−Ripk3−/− mice was completely unexpected. At 
E19 some of these mice were recovered alive by Caesarean section and established regular breathing, 
some failed to establish normal breathing, some appeared edematous and were not recovered alive, 
whilst others were in the process of being resorbed from earlier embryonic lethality. To complicate the 
picture, two viable Shpnm/mCasp8−/−Ripk3−/− mice were obtained at a separate facility. At 3 months 
of age these mice had no epidermal phenotype but were runted. One potential explanation for the 
different penetrance of the phenotype may be a different genetic background because the mice 
described in Figure 8A were exon 3-deleted caspase-8 mice (Beisner et al., 2005), whereas the mice 
if the mice were euthanized due to severe dermatitis. Shpn+/+ or +/m and Shpnm/m mice are highlighted in blue and  
red for reference purposes. Blood was analyzed using an ADVIA 2120 hematological analyzer. RBC: red blood 
cells. Horizontal lines depict data means. Control mice are Shpn+/+ or +/m, for example Tnfr1−/− control mice are 
Shpn+/+ or +/mTnfr1−/−.
DOI: 10.7554/eLife.03464.014
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in Figure 8D were exon 3- and 4-deleted caspase-8 (Salmena et al., 2003). Exon 3- and 4-deleted 
caspase-8 mice in yet a third facility (not shown), however, did not survive past weaning, indicating that 
environmental differences undoubtedly also contribute to the variable penetrance. Future efforts 
aimed at understanding the lethality of Shpnm/mCasp8−/−Ripk3−/− mice should yield important insights 
into not only the biology of SHARPIN and linear ubiquitin, but also that of caspase-8 and RIPK3.
In summary, we provide strong evidence that Sharpin deficiency sensitizes keratinocytes to TNF/
TNFR1-induced, caspase-8-mediated apoptosis, and that this defect appears to drive the cpdm derma-
titis. Ripk3 deletion provided only a modest and variable delay in the presentation of dermatitis. Unlike 
Casp8 heterozygosity, Ripk3 and Mlkl deletion ameliorated many aspects of the systemic cpdm 
phenotype. This indicates a tissue-specific role for Sharpin in regulating cell death pathways. Only 
combined Casp8 heterozygosity and Ripk3 deficiency was able to almost completely prevent all 
aspects of the cpdm systemic phenotype that we evaluated, including the early loss of Peyer's 
patches. Whilst inflammation is a known sequelae to necroptotic DAMP release, these findings 
provide further evidence that excessive apoptosis can also cause inflammatory disease. Furthermore, 
these results indicate that the suppression of cpdm dermatitis seen by crossing to mice lacking 
RIPK1 kinase activity (Berger et al., 2014) may, surprisingly, be due to RIPK1’s kinase activity being 
upstream of caspase-8 in mediating TNF-induced apoptosis.
Materials and methods
Mice
Mice were maintained at the Walter and Eliza Hall Institute of Medical Research (WEHI) and University 
College London (UCL). C57BL/Ka Sharpincpdm/cpdm mice were obtained from Jax (Bar Harbor, ME), and 
then either backcrossed one to two times onto C57BL/6 or crossed with C57BL/6 Ripk3−/−, Mlkl−/−, 
Casp8+/−, Casp8+/-Ripk3−/−, Bid−/−, Il1r1−/−, Tnfr1−/−, or Tnfr2−/− mice. For timed matings, mice were 
analyzed by Caesarean section. For E19 timed matings, pregnant females were injected at E17 and 
E18 with progesterone.
Cell culture and western blotting
Primary keratinocytes and MDFs were isolated and cultured as described previously (Gerlach et al., 2011; 
Etemadi et al., 2013). Cell lysates were prepared using DISC buffer (1% NP-40, 10% glycerol, 150 mM 
NaCl, 20 mM Tris pH 7.5, 2 mM EDTA, cOmplete protease inhibitor cocktail (Roche; Penzberg, Germany), 
2 mM sodium orthovanadate, 10 mM sodium fluoride, β-glycerophosphate, N2O2PO7). Cell lysates were 
loaded in NuPAGE Bis-Tris gels (Life Technologies/Thermo Fisher Scientific; Waltham, MA) and transferred 
on to Immobilon-P PVDF membranes (Millipore; Billerica, MA) or Hybond-C Extra (GE Healthcare; Little 
Chalfont, UK). Membranes were blocked and antibodies diluted in 5% skim milk powder or Bovine Serum 
Albumin (BSA) in 0.1% PBS or TBS-Tween20. Antibodies used for western blot: cleaved caspase-3 
(9661) and −8 (8592), phospho-JNK1/2 (4668P), phospho-p38 (4511), p38 (9212), caspase-8 (4927), 
JNK1/2 (9252), IκBα (CN: 9242), and phospho-p65 (3033) from Cell Signaling Technology (Danvers, MA), 
β-actin (A-1978; Sigma Aldrich; St. Louis, MO), RIPK1 (610458; BD Biosciences; Franklin Lakes, NJ), cFLIP 
(AG-20B-0005; Adipogen; Liestal, Switzerland), FADD (generated in-house; gift from Lorraine O’Reilly) 
and MLKL (generated in house; Murphy et al., 2013). Signals were detected by chemoluminescence 
(Millipore) after incubation with secondary antibodies conjugated to horseradish peroxidase.
For isolation of neutrophils and monocytes, red blood cells were lysed and bone marrow cells were 
stained with flurochrome-conjugated anti-mouse Ig antibodies (CD11b [Mac-1] and Ly6G [1A8]) and sorted 
using a FACS ARIA instrument (BD Biosciences). Neutrophils (CD11b+ Ly6G+) and monocytes (CD11b+Ly6G−) 
were cultured in 5% FCS RPMI at 1 × 105 and 0.5 × 105 cells per well, respectively, in a 96-well u-bottom 
tissue culture plate. BMDMs were isolated and cultured as described previously (Wong et al., 2014).
Death assays
Keratinocytes, MDFs, neutrophils, monocytes, and BMDMs were stimulated with TNF (100 ng/ml), 
Nec-1 (50 μM), QVD-Oph (10 μM, 20 μM for neutrophils and monocytes) and CpdA (911, 500 nM). 
After 24 hr (20 hr for neutrophils and monocytes) all cells except keratinocytes were stained 
with propidium iodide (PI) and cell death analyzed on a FACScalibur instrument (BD Biosciences). 
For the keratinocyte MTS viability assay phenazine methosulfate (PMS; 0.92 mg/ml in PBS; Sigma-Aldrich) 
and 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium (MTS; 
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2 mg/ml in PBS; Promega; Fitchburg, WI) were combined in a 1:20 ratio. The mixture was added to 
cell culture media in a 1:5 ratio and incubated for 1–4 hr at 37°C in a humidified 5% CO2 incubator. 
Media was transferred to a flat-bottom 96-well plate and absorbance was measured at 490 nm. 
Viability was calculated relative to the untreated sample.
For HaCaT experiments, cells stably expressing HOIP, HOIPC885S (catalytically inactive), or an empty 
vector were seeded and incubated the next day with 100 ng/ml histidine-tagged TNF for 24 hr. 
Supernatant and adherent cells were harvested and resuspended in PBS containing 5 mg/ml PI. 
PI-positive cells were measured by flow cytometry (BD Accuri; BD Biosciences).
Histology and immunofluorescence
Paraffin-embedded tissue was fixed in 10% neutral buffered formalin then processed and stained 
with hematoxylin and eosin (H&E) according to standard practices. Immunohistochemistry and immu-
nofluorescence analysis was performed as described previously (Rickard et al., 2014).
Reconstitution experiments
Ly5.1 mice were irradiated with 2 × 550 rads spaced 3 hr apart. Following red blood cell lysis, ∼ 5 × 106  
BM cells from Shpnm/m (Ly5.2) mice were intravenously injected. Mice were maintained on 2 mg/ml 
neomycin in drinking water for 3 weeks post irradiation. Reconstitution efficiency was assessed 6 weeks 
and 12 months post reconstitution by staining for Ly5.1 and Ly5.2 in peripheral blood obtained from 
retro-orbital bleeding.
Cytokine BioPlex assay
Cytokines were analyzed using a BioPlex Pro mouse cytokine 23-plex kit (Bio-Rad; Hercules, CA), or for 
analysis of TNF levels a mouse TNF ELISA kit (eBioscience; San Diego, CA) was used. Skin lysates were 
prepared by homogenizing skin in ice cold protein lysis buffer (20 mM Tris pH 7.5, 150 mM NaCl, 2 mM 
EDTA, 1% Triton-X100, 10% glycerol) using a Tissue Lyser II (QIAGEN; Hilden, Germany) for 12 cycles 
of 30 s at 30 Hz. A BCA kit (Thermo Fisher Scientific) was used to normalise protein levels. Values 
below the reference range were assigned the value of the lowest standard.
ADVIA blood analysis
Peripheral blood was collected into EDTA tubes (Sarstedt; Nümbrecht, Germany) and analyzed using 
an ADVIA 2120 hematological analyzer.
TNF-RSC immunoprecipitation
For TNF-RSC isolation, immortalised MEFs were stimulated with 3xFlag-2xStrep-TNF at 0.5 μg/ml 
for the indicated times, or left untreated. Cells were subsequently solubilized in lysis buffer (30 mM 
Tris–HCl (pH 7.4), 150 mM NaCl, 2 mM EDTA, 2 mM KCl, 10% Glycerol, 1% Triton X100, EDTA-free 
proteinase inhibitor cocktail (Roche) and 1x phosphatase inhibitor cocktail 2 (Sigma Aldrich)) at 4°C 
for 30 min. The lysates were cleared by centrifugation, and 3xFlag-2xStrep-TNF was added to the 
untreated samples. Next, lysates were subjected to anti-Flag immunoprecipitation using M2 beads 
(Sigma Aldrich) for 16 hr. The beads were washed three times with lysis buffer, proteins were eluted 
in 50 μl of LDS buffer (Life Technologies/Thermo Fisher Scientific) containing 50 mM DTT. Samples 
were analyzed by western blotting. Antibodies used were: HOIP (custom-made, Thermo Fisher 
Scientific), SHARPIN (14626-1-AP; ProteinTech; Chicago, IL), TNFR1 (ab19139; Abcam; Cambridge, UK), 
and linear ubiquitin (Genentech; South San Francisco, CA).
Statistics
Pearson chi-square and Fisher's exact test were used to assess frequencies of observed vs expected geno-
types during development, at birth, and at weaning. Fisher's exact test was used for epidermal thickness 
statistical calculations. Student's t test was used to calculate statistical significance shown for all other data.
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